These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12716352)

  • 21. Chronic paroxysmal hemicrania-tic syndrome.
    Zukerman E; Peres MF; Kaup AO; Monzillo PH; Costa AR
    Neurology; 2000 Apr; 54(7):1524-6. PubMed ID: 10751271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The selective Cox-2 inhibition by rofecoxib reduces risk of severe gastrointestinal complications of anti-inflammatory therapy by more than 50%].
    Kellner H
    Z Gastroenterol; 2001 May; 39(5):443-5. PubMed ID: 11413920
    [No Abstract]   [Full Text] [Related]  

  • 23. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
    Krymchantowski AV; Barbosa JS
    Cephalalgia; 2002 May; 22(4):309-12. PubMed ID: 12100094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rofecoxib (Vioxx), a specific cyclooxygenase-2 inhibitor, is chemopreventive in a mouse model of colon cancer.
    Evans JF
    Am J Clin Oncol; 2003 Aug; 26(4):S62-5. PubMed ID: 12902858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.
    Higuchi T; Iwama T; Yoshinaga K; Toyooka M; Taketo MM; Sugihara K
    Clin Cancer Res; 2003 Oct; 9(13):4756-60. PubMed ID: 14581346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rofecoxib-induced pseudoporphyria.
    Markus R; Reddick ME; Rubenstein MC
    J Am Acad Dermatol; 2004 Apr; 50(4):647-8. PubMed ID: 15034522
    [No Abstract]   [Full Text] [Related]  

  • 27. Comment on efficacy of rofecoxib and nimesulide in controlling post-extraction pain in oral surgery: a randomised comparative study.
    Villa G
    Curr Med Res Opin; 2004 Apr; 20(4):573-4; author reply 574. PubMed ID: 15119995
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemicrania horologica ("clock-like hemicrania").
    Granella F; D'Andrea G
    Neurology; 2003 May; 60(10):1722-3. PubMed ID: 12771283
    [No Abstract]   [Full Text] [Related]  

  • 29. A quantitative evaluation of the regulatory assessment of the benefits and risks of rofecoxib relative to naproxen: an application of the incremental net-benefit framework.
    Lynd LD; Marra CA; Najafzadeh M; Sadatsafavi M
    Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1172-80. PubMed ID: 20602338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rofecoxib (Vioxx) withdrawal: do product monographs adequately inform physicians?
    Can Fam Physician; 2005 Feb; 51(2):212-3. PubMed ID: 15751564
    [No Abstract]   [Full Text] [Related]  

  • 31. [Meta-analysis on acute pain. Rofecoxib helped three quarters of patients].
    MMW Fortschr Med; 2003 Aug; 145(31-32):57. PubMed ID: 14524084
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.
    Katz N; Ju WD; Krupa DA; Sperling RS; Bozalis Rodgers D; Gertz BJ; Gimbel J; Coleman S; Fisher C; Nabizadeh S; Borenstein D;
    Spine (Phila Pa 1976); 2003 May; 28(9):851-8; discussion 859. PubMed ID: 12941996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The paroxysmal hemicrania-tic syndrome.
    Boes CJ; Matharu MS; Goadsby PJ
    Cephalalgia; 2003 Feb; 23(1):24-8. PubMed ID: 12534576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial.
    Morrison BW; Christensen S; Yuan W; Brown J; Amlani S; Seidenberg B
    Clin Ther; 1999 Jun; 21(6):943-53. PubMed ID: 10440619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans.
    Schwartz JI; Chan CC; Mukhopadhyay S; McBride KJ; Jones TM; Adcock S; Moritz C; Hedges J; Grasing K; Dobratz D; Cohen RA; Davidson MH; Bachmann KA; Gertz BJ
    Clin Pharmacol Ther; 1999 Jun; 65(6):653-60. PubMed ID: 10391671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cox-2 inhibitors in the focus. Rofecoxib as effective as the "classics"].
    MMW Fortschr Med; 2001 Nov; 143(46):50-1. PubMed ID: 11759601
    [No Abstract]   [Full Text] [Related]  

  • 37. Intracranial hypertension induced by rofecoxib.
    Jacob S; Rajabally YA
    Headache; 2005 Jan; 45(1):75-6. PubMed ID: 15663617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bartter syndrome: benefits and side effects of long-term treatment.
    Vaisbich MH; Fujimura MD; Koch VH
    Pediatr Nephrol; 2004 Aug; 19(8):858-63. PubMed ID: 15206026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rofecoxib: a new selective COX-2 inhibitor.
    Rajadhyaksha VD; Dahanukar SA
    J Postgrad Med; 2001; 47(1):77-8. PubMed ID: 11590304
    [No Abstract]   [Full Text] [Related]  

  • 40. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group.
    Cannon GW; Caldwell JR; Holt P; McLean B; Seidenberg B; Bolognese J; Ehrich E; Mukhopadhyay S; Daniels B
    Arthritis Rheum; 2000 May; 43(5):978-87. PubMed ID: 10817549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.